Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma 14Leukemia 14Breast Neoplasms 9Lymphoma, Large B-Cell, Diffuse 7Osteosarcoma 5Gestational Trophoblastic Disease 4Central Nervous System Neoplasms 4Meningeal Carcinomatosis 3Lymphoma, Extranodal NK-T-Cell 3Astrocytoma 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Oligodendroglioma 2Myelodysplastic Syndromes 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Leukemia, T-Cell 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Drug-Related Side Effects and Adverse Reactions 2Dendritic Cell Sarcoma, Interdigitating 2Choroid Plexus Neoplasms 2Burkitt Lymphoma 2Water Intoxication 1Thrombocythemia, Essential 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1

Interventions

Methotrexate 1Dietary Fiber 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Psoriasis × Methotrexate × Clear all
NCT03424629 2018-04-20

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Tianjin Ever Union Biotechnology Co., Ltd.

Phase 1 Unknown
57 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡